ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


The drugs trial for Eculizumab [ECUSTEC} started in July of this year.

29th October 2017

The drugs trial for Eculizumab known as [ECUSTEC} started in July of this year. Six of the twelve participating hospitals are now open to recruitment.

The trial will only include patients who are under the age of 18.

When these young people are considered for the trial their parents will be given sufficient written information etc to ensure they can make an informed choice before they decide if they want to participate. (If the patient is 16 to 18 they will also be given the information themselves).

As a charity, we support the trial and are co-applicants on the basis that, at the present time there is no specific treatment known to help reduce the severity that some sufferers of Haemolytic Uraemic Syndrome (HUS) can experience. We do not know whether or not it will work but are encouraged that this drug has been shown to be successful when used for a similar condition known as aHUS.

We appreciate that this is a difficult decision for parents to make when their child is ill, but we wish them well in whatever choice they make.




Page
1 of 50
Next > Last >>

12th August 2025

The UK Health Security Agency (UKHSA) published the Shiga toxin-producing Escherichia coli (STEC) data in England during 2024 on 30... ...read on
29th June 2025

According to the UK Health Security Agency (UKHSA) data published on the 26th June 2025 for the year 2024 in the Link below, Cases of Salmonella and Campylobacter are the highest in a decade. ... ...read on
27th May 2025

There were 2063 cultured confirm... ...read on
24th April 2025

16th April 2025    Case Reference: IC-348... ...read on
5th March 2025

The Information Commissioner's office (ICO) Freedom of Information decision notice of 05/03/2025 stated    ... ...read on
Page
1 of 50
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy